Advanced imaging to improve breast cancer diagnosis and treatment decisions
Official title: The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer
Run by Yunnan Cancer Hospital · NCT07608081 · Data updated 2026-11-12
This study tests whether multiple advanced MRI techniques can more accurately diagnose breast cancer and help tailor treatment for women with suspicious breast lesions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | Yunnan Cancer Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Kunming, Yunnan) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | October 1, 2027 |
| Study ends | October 1, 2027 |
| Registry record updated | May 27, 2026 |
| Trial ID | NCT07608081 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with BI-RADS 4 or higher breast lesions who can undergo the specified MRI examinations within one week before biopsy or surgery.
✕Probably not a fit
Patients whose lesions are clearly benign on standard imaging or who cannot complete MRI procedures may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial enrolls adult women with BI-RADS 4 or higher breast lesions and uses ultrafast DCE-MRI, time-dependent diffusion MRI, MR elastography, and virtual MR elastography before biopsy or surgery to collect imaging and clinical data. Researchers will analyze how these imaging modalities together may improve precision in diagnosis, treatment planning, and prognosis. The study aims to create a robust imaging basis to guide individualized care and potentially improve outcomes and resource use.
Why it matters
Potential benefit: If successful, patients may receive more accurate diagnoses and more precisely targeted treatment plans.
How similar studies have gone: Multimodal MRI approaches have shown promise in improving characterization of breast lesions, but this exact combination is relatively novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. Female patients with BI-RADS class 4 or above breast lesions detected by mammography or ultrasound 3. Perform breast new technology MRI examination (ultra fast DCE-MRI、OGSE 、MRE、vMRE)within one week before biopsy or surgery Exclusion Criteria: 1. Previously received breast radiotherapy, chemotherapy, surgery, or targeted therapy 2. Unable to cooperate in completing MRI examination 3. The image data contains serious artifacts (such as motion artifacts and metal artifacts), making it impossible to measure parameters 4. The lesion cannot be clearly identified and outlined on the image 5. Pregnant and lactating women 6. Combined with severe liver, liver, and kidney diseases, coagulation dysfunction, or other malignant tumors
Where it's running
-
Yunnan Cancer Hospital
Kunming, Yunnan, China Recruiting
Study contacts
- Study coordinator: Caiyang Li
- Email: 2020429049@kmmu.edu.cn
- Phone: +8613658700171
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.